Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b trial of lersivirine vs efavirenz in treatment-naive HIV-1 infection
2007-004379-20Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lersivirine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Pfizer. Primary endpoint: Virologic suppression <50 copies/mL at Week 48. Started Nov 2008; status: completed.
02
Drugs
lersivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-004379-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004379-20.